In this new episode, Marcus R. Burns, DNP, RCIS, AACC, Structural Interventional Cardiology at Minneapolis Heart Institute (MHI)/Abbott Northwestern, shares how his team evaluated their own small-annulus TAVR outcomes and compared their real-world experience with findings from the SMART trial. Marcus discusses what prompted the analysis, how his team collected and followed their institutional data through three years, and how their findings compared with trends observed in SMART. He also shares how these insights have influenced their approach to valve selection, hemodynamics, longitudinal follow-up, and heart-team decision-making for patients with small annuli.

Angel Caldera, MD, interviews Paul Mahoney, MD, on TAV-in-SAV for failed bioprosthetic valves. They review patient selection, valve sizing, and coronary obstruction risk using CT planning. The discussion highlights leaflet modification, stroke considerations, anticoagulation strategies, and the ever-evolving balance between redo surgery and transcatheter approaches.

Dr. Lucas Seibolt and Dr. Rony Lahoud examine the complexities of treating bicuspid aortic valve disease in the TAVR era. This episode dives into anatomical considerations, procedural nuances, and emerging data—offering insights to help clinicians navigate one of the field’s most persistent challenges.